Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Haemonetics Corporation (HAE) had Weighted-Average Shares Outstanding (Diluted) of 45.70M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$339.38M |
|
$33.01M |
|
$136.58M |
|
$202.80M |
|
$281.92M |
|
$57.46M |
|
$-9.88M |
|
$47.57M |
|
$47.57M |
|
$33.01M |
|
$33.01M |
|
$33.01M |
|
$33.01M |
|
$57.46M |
|
$84.57M |
|
45.36M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
45.70M |
$0.73 |
|
$0.72 |
|
| Balance Sheet Financials | |
$810.83M |
|
$303.78M |
|
$1.55B |
|
$2.37B |
|
$263.24M |
|
$1.17B |
|
$1.27B |
|
$1.53B |
|
$837.10M |
|
$-254.29M |
|
$837.10M |
|
45.47M |
|
| Cash Flow Statement Financials | |
$52.32M |
|
$-22.23M |
|
$-51.53M |
|
$245.44M |
|
$223.38M |
|
$-22.06M |
|
$9.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.08 |
|
-- |
|
-- |
|
0.58 |
|
1.40 |
|
59.76% |
|
16.93% |
|
16.93% |
|
-- |
|
14.02% |
|
9.73% |
|
$44.65M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.45 |
|
1.57 |
|
57.30 |
|
3.94% |
|
-12.98% |
|
1.40% |
|
1.65% |
|
$18.41 |
|
$0.98 |
|
$1.14 |
|